Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report issued on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright decreased their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a report on Monday, June 24th.

Aethlon Medical Stock Performance

Aethlon Medical stock opened at $0.38 on Friday. The company has a market capitalization of $5.35 million, a PE ratio of -0.08 and a beta of 1.72. The company has a 50 day moving average price of $0.39 and a 200-day moving average price of $0.87. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.84.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same quarter in the previous year, the business earned ($1.30) EPS. On average, analysts forecast that Aethlon Medical will post -1.1 earnings per share for the current year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.